BioOutsource expands in Scotland; EU carries on with ban of GVK-tied drugs;

> BioOutsource, recently acquired by Sartorius Stedim Biotech, has opened a new facility in its native Scotland to support the development of biosimilars, planning to add 50 jobs in the process. More

> European regulators are standing by their decision to suspend the marketing of more than 700 drugs tied to a data scandal at GVK BioSciences, planning to institute a ban starting Aug. 21. News